T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma
1 clinical trials · Condition
◉ Watch T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma (NCT00807495) | Millennium Pharmaceuticals, Inc. | 2009-02-10 |
Track T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.